P-035 Simultaneous carcinoembryonic antigen (CEA), carcinoma antigen 19-9 (CA 19-9) and 125 (CA-125) measurement in patients with gastric cancer (stage IA-IB): a case-control study

Ítems similars

• P-024 Carcinoembryonic antigen (CEA) and the carcinoma antigen 19-9 (CA 19-9) together in early diagnosis of Stage I-II colorectal adenocarcinoma. A case-control study
  per: Lumachi, F., et al.
  Publicat: (2016)
• REFLECTION ON THE DISCOVERY OF CARCINOEMBRYONIC ANTIGEN, PROSTATE-SPECIFIC ANTIGEN AND CARBOHYDRATE ANTIGENS CA125 and CA19.9
  per: Diamandis, Eleftherios P., et al.
  Publicat: (2012)
• Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
  per: Kuusela, P., et al.
  Publicat: (1984)
• The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma
  per: Jaklitsch, Manuel, et al.
  Publicat: (2019)
• Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
  per: Haglund, C.
  Publicat: (1986)